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Genital sarcomas in pregnancy are extremely rare. A review by Ma-
tsuo et al. covering the period 1955 to 2007 revealed a total of 40 cases
of female genital sarcomas diagnosed during pregnancy; 37.5% uterine,
27.5% retroperitoneal, 22.5% vulvar sarcoma, and 12.5% vaginal (Matsuo
et al., 2009). Mean age at diagnosis was 27.8 years and the majority of
cases were diagnosed in the third trimester. The 5 year survival for all
patients was quite poor at 22.2%. Leiomyosarcoma of the uterine cervix
associated with pregnancy has not been previously reported. In this re-
port we describe the case of a gravid patient with a leiomyosarcoma
conﬁned to the cervix.
1.1. Case
An 18 year-old female Gravida 3 Para 1011 presented to an outside
clinic with several months of vaginal bleeding and abdominal pain.
She was diagnosed with an intrauterine pregnancy with an estimated
gestational age (EGA) of 27 weeks based on dating by ultrasound. She
was also noted to have an exophytic mass protruding from the
endocervical canal. Subsequent examination under anesthesia revealed
a 4.2 × 3.9 cm, pedunculated mass, arising from the endocervical canal.
The mass was resected and pathology was consistent with a
leiomyosarcoma.
The patient was referred to our institution at 31 weeks EGA for con-
sultation with maternal fetal medicine (MFM) and gynecologic oncolo-
gy. Physical examination was consistent with a normally developed
young woman, normotensive, with a BMI of 26. Ultrasound evaluation
showed an appropriately grown female fetus with a normal anatomic
survey. Pelvic examination showed normal external female genitalia
and vaginal tube. The cervix was 50% effaced and the external cervical
os was 1 cm dilated. There was a remnant of a stalk at the 9:00 position
in the proximal endocervical canal.
Pathology review at our institution revealed a 4.2 cm smooth polyp-
oid ﬂeshy mass on a narrow stalk. Microscopic examination revealed a. This is an open access article undercellular spindle cell neoplasm composed of highly atypical and focal bi-
zarre giant cells with a high mitotic rate (11 mitoses/10 high power
ﬁelds). Marked cytologic atypia was diffuse, but tumor cell necrosis
was not prominent (Figs. 1, 2). Subsequent immunostaining showed
the tumor to be focally positive for smooth muscle actin and muscle
speciﬁc actin. Desmin, caldesmon, AE1/AE3, S100 and HMB45 were
negative; p53 stained a few scattered nuclei; p16 showed strong diffuse
block staining; Ki67 showed a high proliferation rate. A diagnosis of high
grade leiomyosarcoma was made which was conﬁrmed by expert con-
sultation. The non-ulcerated surface was covered by benign
endocervical epithelium conﬁrming a submucosal conﬁguration (Fig.
3). The tumor appeared to involve the entire polyp. While there was a
small amount of stroma at the surgical margin, a deﬁnitive assessment
of the margin status was not possible.
Computerized tomography of the chest, abdomen, and pelvis dem-
onstrated a gravid uterus with no evidence of metastatic disease. After
counseling by MFM and based on the pathology showing a high grade
leiomyosarcoma the decision was made for delivery of the fetus at 33
to 34weeks. She completed corticosteroids at 31 2/7weeks. Shewas ad-
mitted with preterm labor and received a rescue dose of corticosteroids
at 33 1/7 weeks. Assessment of fetal lung maturity was not performed.
The patient desired deﬁnitive management of the high grade
leiomyosarcoma and underwent primary low transverse cesarean sec-
tion followed by exploratory laparotomy, total abdominal hysterecto-
my, and bilateral salpingectomy at 33 2/7 weeks. She delivered a
viable female infant with APGARS 6 and 8 and weight of 2180 g. Intra-
operative ﬁndings included normal ovaries and fallopian tubes and no
evidence of extra-uterine disease. Final pathology showed no residual
leiomyosarcoma. The patient had an uncomplicated postoperative
course and has no evidence of recurrent disease by clinical exam and
CT scan of the chest, abdomen, and pelvis at 13 months from her diag-
nosis. The infant was admitted to the neonatal intensive care unit
post-delivery. She was treated for 3 days with phototherapy for
hyperbilirubinemia. She required supplemental oxygen therapy for
9 days for transient tachypnea of the new born. She was discharge to
home on day of life 19 with no feeding or other issues. At 1 year of life
her pediatric examination showed normal growth and she had met
her developmental milestones.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. The tumor is composed of atypical spindle cells (H&E, 20×). Fig. 3. The pedunculated tumor is lined by endocervical epithelium which is apposed to
the underlying endocervical canal (H%E, 400x).
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We performed a literature search in PubMed andMedline databases
without language restriction from 1960 to 2016. All articles were initial-
ly screened for title and abstract and full texts of eligible articles were
subsequently selected. The search terms were “sarcoma, cervix, preg-
nancy, and leiomyosarcoma”. Four case reports were discovered. Table
1 shows a summary of reports of cervical sarcomas in pregnancy. The
3 early case reports did not characterize the type of sarcomas using
modern diagnostic criteria and nomenclature (Diaz-Bazan and
Masferrer, 1960; Adinolﬁ and Persico, 1961; Onarir et al., 1967). The
modern diagnosis of leiomyosarcoma is based on the work of Bell et
al. (1994) and includes a combination of features includingdiffusemod-
erate to severe cellular atypia, a mitotic count of ≥10 MFs/10 HPFs, and
coagulative tumor cell necrosis (Bell et al., 1994). Generally tumorswith
any 2 of these 3 features are diagnosed as clinically malignant
leiomyosarcoma. The clinical circumstances of the case report by
Schiavone et al. was quite similar to the current case, although the sar-
coma in their case was called “high-grade” rather than leiomyosarcoma
based on inconclusive immunohistochemical staining (Schiavone et al.,
2011).
The diagnosis of leiomyosarcoma diagnosed during pregnancy re-
quires expert pathological evaluation. The diagnosis of sarcoma in preg-
nancy can be difﬁcult due to pregnancy induced histologic changes seenFig. 2. The tumor contains numerous mitoses (H&E, 400×).in benign leiomyomata including hemorrhage, necrosis, and degenera-
tive changes.Muezzinoglu et al. in a reviewof leiomyomas in pregnancy
described several cases of smooth muscle tumors with extensive hya-
line and infarct necrosis (Muezzinoglu and Corakci, 1996). Coagulative
cell necrosis was not observed. Cellular atypia when present was mild
and focal and usually associated with hyaline type necrosis. Mitotic ac-
tivity was low, less than 5/10 HPF. The diagnosis of leiomyosarcomas
that meet the “three-feature” Bell criteria are considered high grade tu-
mors (Bell et al., 1994). In the current case the tumor met the criteria
proposed by Bell and was considered a high grade leiomyosarcoma.
Fertility sparing management options should be considered and
discussed with patients desirous of future childbearing. In certain se-
lected cases, surgical procedures such as myomectomy, polypectomy,
and conization, during or after pregnancy, and dilation and curettage
after delivery, could be performed. If no residual disease is found, sur-
veillance rather than hysterectomy could be considered. Good out-
comes and subsequent pregnancy have been reported with
conservative surgery for patents with uterine smooth muscle tumor of
uncertain malignant potential and low grade uterine leiomyosarcoma
(Campbell et al., 2015; Salman et al., 2007). In the current case expert
pathologic examination conﬁrmed a high grade cervical
leiomyosarcoma. Extrapolating from the literature on uterine
leiomyosarcoma, high grade has been shown to a signiﬁcant risk factor
for recurrence and death and hysterectomy is considered the treatment
of choice (Giuntoli et al., 2003).
In the current case CT scanwas used as the imagingmodality and the
chest, abdomen, and pelvis were evaluated. The dose of radiation deliv-
ered to the fetus was 20 to 50 mGy which is below the dose threshold
for malformations, growth retardation, mental retardation, and death;
however, the risk of carcinogenesis increases approximately by a factor
of 2, although it remains low in absolute term, less than one in 250
(Tremblay et al., 2012). Ultrasound and magnetic resonance imaging
are not associated with risk and are the imaging modalities of choice
in a pregnant patient.
The decision to deliver at 33 2/7 weeks EGA was based on several
factors. The timing of delivery is based on the balance between the
risk of cancer progression and the risk of delivery of a premature
fetus. Leiomyosarcomas are aggressive tumors and patients whose dis-
ease appears to be initially conﬁned to the uterusmay experience a clin-
ically aggressive disease course (Giuntoli et al., 2003). There is quite
limited experience with leiomyosarcomas in pregnancy. Based on the
uncertain pathologicmargin status and the appearance of a residual cer-
vical stalk on speculum exam there was a concern for residual disease.
The patient was extensively counseled concerning natural history of
Table 1
Literature review of cervical sarcoma in pregnancy.
Source Age,
y
Gravity,
parity
EGA Mode of diagnosis Gross ﬁndings Microscopic diagnosis Treatment Pathology Follow
up
Diaz-Bazan and
Masferrer (1960)
24 G3P2 7 Dilation and evacuation.
Excision of cervical lesion
Cervical lesion
(NOS)
Polypoid form, fusiform
type, sarcoma
Radical hysterectomy,
BSO, LND
No residual
sarcoma
NED at 5
years
Adinolﬁ and Persico
(1961)
29 G7P5025 pp Cervix biopsies 5 cm cervical
mass
Small blue cell, alveolar
type, sarcoma
Hysterectomy and
radiation therapy
Residual
sarcoma
ND
Onarir et al. (1967) 30 ND 9 Cervix biopsies Cervical lesion
(NOS)
Sarcoma (NOS) Hysterectomy with
fetus in-utero
Residual
sarcoma
ND
Schiavone et al.
(2011)
27 G2P1 25 Removal of endocervical polyp Small
endocervical
polyp
High grade sarcoma
(NOS)
Cesarean
hysterectomy,
healthy fetus
No residual
sarcoma
ND
Whitcombe et al. 18 G2P1 27 Excision of endocervical mass 4 cm mass
endocervical
mass
Leiomyosarcoma Cesarean
hysterectomy, healthy
fetus
No residual
sarcoma
NED at 1
year
Note: y — year; PP — postpartum; EGA — estimated gestational age; NOS— not otherwise speciﬁed; BSO — bilateral salpingo-oophorectomy; LND — pelvic and para-aortic lymph node
dissection; NED — no evidence of disease; ND— no data.
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2/7 weeks.
Prevention of iatrogenic prematurity is an important part of the
treatment strategy for managing pregnant patients with cancer. Van
Calsteren et al. recently published their experience examining 215preg-
nancies complicated by cancer (Van Calsteren et al., 2010). The authors
found that iatrogenic prematurity complicated 54.2% of cases. ACOG de-
ﬁnes late preterm birth as the delivery of an infant between 34 and
36 weeks and 6 days of gestation. During the birth hospitalization, the
late preterm infants compared with term infants are more likely to
have hypothermia, hypoglycemia, respiratory distress, apnea,
hyperbilirubinemia, and feeding difﬁculties (Leone et al., 2012). There
is conﬂicting data concerning long-term neurodevelopmental morbidi-
ty including cognition, achievement, social skills, and behavioral/emo-
tional problems (Gurka et al., 2010; Harris et al., 2013). Our institution
is a tertiary care, referral medical center, with a level 4 NICU, with ma-
ternal fetal medicine and gynecologic oncology services. The intact sur-
vival at 33 to 34 weeks at our institution very much depends on the
condition of the fetus, i.e. presence or absence of congenital abnormali-
ties, IUGR, etc., and the indication for delivery, i.e. premature rupture of
membranes, intra-amniotic infection, etc. In the current case we had a
healthy, appropriately grown, fetus and the indication for delivery was
based on maternal indications. At our institution the intact survival in
this scenario is the same as term infants. At 1 year of life the infant
shows normal growth and neurocognitive development. It is important
that pregnant cancer patients are treated in a multidisciplinary setting
with access to maternal fetal medicine specialists, neonatologists, and
oncologists. It is imperative that these patients are treated in a hospital
with access to neonatal intensive care units as iatrogenic preterm deliv-
ery in not uncommon. Long term care of the premature infant should in-
clude regular neurocognitive and developmental assessments.
A simple hysterectomy rather than radical hysterectomy was per-
formed in the current case. The tumorwas clinically conﬁned to the cer-
vix with no parametrial or vaginal extension. Leiomyosarcomas
typically metastasize via a hematogenous route. There have been no re-
ported cases of cervical leiomyosarcoma with occult parametrial in-
volvement and lymphatic metastasis is a rare event (Bansal et al.,
2010). In contrast, carcinoma of the cervix typically invades the cervical
stroma and lymphatic vascular spaces with subsequent metastasis to
the parametrial and pelvic lymph nodes (Girardi et al., 1989). The radi-
cal hysterectomy is used primarily to treat early stage carcinoma of the
cervix. Surgical management includes removal of the primary tumor
with hysterectomy and assessment for metastatic disease. Exploration
of the abdomen and pelvis is performed and suspicious lesions biopsied.
The ovariesmay be preserved in selected patientswith early-stage uter-
ine leiomyosarcoma who wish to retain hormonal function. No differ-
ence in disease-speciﬁc survival and recurrence rates were found
between patients with and without oophorectomy (Kapp et al., 2008;Leitao et al., 2003). In the current case based on the patient's young
age and extrapolating from theuterinedata, the ovarieswere preserved.
Routine lymphadenectomy at primary surgery is not recommended for
uterine leiomyosarcoma. Lymphadenectomy failed to have any prog-
nostic signiﬁcance, as the 5-year disease-speciﬁc survival was similar
between those who had and had not undergone lymphadenectomy
(Kapp et al., 2008; Leitao et al., 2003). Bansal et al. analyzing SEER
data from 1988 to 2005 identiﬁed 67 non-gravid patients with cervical
leiomyosarcoma (Bansal et al., 2010). None of the patients had positive
lymph nodes. In the current case there was no evidence of lymphade-
nopathy on CT scan or at surgical exploration and a lymphadenectomy
was not performed. Our patient did not receive postoperative chemo-
therapy. Adjuvant chemotherapy for patients with stage I uterine
leiomyosarcoma is controversial (Hensley et al., 2013).
The surveillance recommendations for high grade cervical
leiomyosarcoma were extrapolated from the NCCN guidelines version
2.2016 for high grade uterine sarcoma (Guidelines, 2015). The recom-
mendations include history and physical examination every 3 months
for 2 years, then every 6 to 12 months, CT imaging of the chest, abdo-
men, and pelvis every 3 to 6 months for 2 to 3 years, then every
6months for thenext two years, then annually, and education regarding
the symptoms of potential recurrence, lifestyle, obesity, exercise, and
nutrition, and smoking cessation counseling. Patients should be educat-
ed regarding sexual health, vaginal dilator use, and vaginal lubricants
and moisturizers.
In summary, we report a case of leiomyosarcoma of the cervix diag-
nosed in pregnancywith a good outcome for bothmother and baby.We
advocate expert pathology review in the clinical setting of suspected
sarcoma in pregnancy. The decision of timing of delivery is made after
thorough patient counseling by MFM, neonatology, and oncology
concerning the risks of prematurity and the risk of cancer progression.
Due to the rarity of cervical leiomyosarcomasmanagement recommen-
dations are based on data extrapolated from experience with uterine
leiomyosarcoma; including hysterectomy, ovarian preservation, and
omission of lymphadenectomy.
Written informed consent was obtained from the patient for publi-
cation of this case report and accompanying images. A copy of the writ-
ten consent is available for review by the Editor-in-Chief of this journal
on request.
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